Cell and gene therapies: on course for commercial success? – PMLiVE
PMLiVE |
Cell and gene therapies: on course for commercial success?
PMLiVE Funding and reimbursement of cell and gene therapies pose a major challenge as payers consider how to evaluate a commercial proposition that is completely divergent from the traditional pharmaceutical model. Commenters, including the Regenerative … |
